Few patient, treatment, and diagnostic or microbiological factors, except complications and intermittent negative cerebrospinal fluid (CSF) cultures during first CSF shunt infection, are associated with reinfection

Journal of the Pediatric Infectious Diseases Society

Volumn 3, Issue 1, 2014, Pages 15-22

  Simon, Tamara D ^a,b   Mayer Hamblett, Nicole ^a,b   Whitlock, Kathryn B ^b   Langley, Marcie ^c   Kestle, John R W ^c,d   Riva Cambrin, Jay ^c   Rosenfeld, Margaret ^a,b   Thorell, Emily A ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Children; Infection; Shunt

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; RIFAMPICIN;

ARTICLE; BACTEREMIA; BRAIN VENTRICULITIS; CEREBROSPINAL FLUID SHUNTING; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; ENTEROCOCCUS FAECALIS; FEMALE; FOLLOW UP; GRAM STAINING; HUMAN; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEWBORN; NONHUMAN; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOCYST; PSEUDOMONAS AERUGINOSA; REINFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SHUNT INFECTION; STAPHYLOCOCCUS AUREUS; VENTRICULOATRIAL SHUNT; ABDOMINAL ABSCESS; BACTERIAL INFECTION; CEREBROSPINAL FLUID CULTURE; CONTROLLED STUDY; CYST FLUID; LIQUORRHEA; MEDICAL DECISION MAKING; PATIENT RISK; SUBDURAL HEMATOMA; SURGICAL SWAB;

EID: 84904089057     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pit050     Document Type: Article

References (32)

1. Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 2006; 22: 692-7.
2. Frykberg T, Olden L. Infection as a cause of peritoneal catheter dysfunction in ventriculo-peritoneal shunting in children. Z Kinderchir 1983; 38(Suppl 2):84-6.
3. Amacher AL, Wellington J. Infantile hydrocephalus: long-term results of surgical therapy. Childs Brain 1984; 11:217-29.
4. Cochrane DD, Kestle JR. The influence of surgical operative experience on the duration of first ventriculoperitoneal shunt function and infection. Pediatr Neurosurg 2003; 38: 295-301.
5. Kestle J, Drake J, Milner R, et al. Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 2000; 33: 230-6.
6. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 1995; 136(1-2):1-7.
7. Di Rocco C, Marchese E, Velardi F. A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus. Cooperative survey of the 1991-1992 Education Committee of the ISPN. Childs Nerv Syst 1994; 10:321-7.
8. Simon TD, Hall M, Riva-Cambrin J, et al. Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article. J Neurosurg Pediatr 2009; 4:156-65.
9. Simon TD, Whitlock KB, Riva-Cambrin J, et al. Revision surgeries are associated with significant increased risk of subsequent cerebrospinal fluid shunt infection. Pediatr Infect Dis J 2012; 31: 551-6.
10. Simon TD, Whitlock KB, Riva-Cambrin J, et al. Association of intraventricular hemorrhage secondary to prematurity with cerebrospinal fluid shunt surgery in the first year following initial shunt placement. J Neurosurg Pediatr 2012; 9:54-63.
11. McGirt MJ, Zaas A, Fuchs HE, et al. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003; 36:858-62.
12. Odio C, McCracken GH Jr, Nelson JD. CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child 1984; 138: 1103-8.
13. Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP. Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 1984; 60: 1014-21.
14. Kestle JR, Garton HJ, Whitehead WE, et al. Management of shunt infections: a multicenter pilot study. J Neurosurg 2006; 105(3 Suppl):177-81.
15. Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM. Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 2001; 35:66-71.
16. Whitehead WE, Kestle JR. The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg 2001; 35: 205-10.
17. Simon TD, Hall M, Dean JM, et al. Reinfection following initial cerebrospinal fluid shunt infection. J Neurosurg Pediatr 2010; 6: 277-85.
18. Tuan TJ, Thorell EA, Hamblett NM, et al. Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 2011; 30:731-5.
19. Kestle JR, Riva-Cambrin J,Wellons JC 3rd, et al. A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative. J Neurosurg Pediatr 2011; 8:22-9.
20. Simon TD, Riva-Cambrin J, Srivastava R, et al. Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths. J Neurosurg Pediatrics 2008; 1:131-7.
21. Committee on Infectious Diseases, Pediatrics AAp. Section 3: Summaries of Infectious Diseases, Non-Group A or B Streptococcal and Enterococcal Infections. Red Book: 2012 Report of the Committee on Infectious Diseases. In: Pickering LK, ed. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012; 686-8.
22. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 2001; 94:195-201.
23. Williams MA, McAllister JP, Walker ML, et al. Priorities for hydrocephalus research: report from a National Institutes of Healthsponsored workshop. J Neurosurg 2007; 107i(5 Suppl):345-57.
24. Sells CJ, Shurtleff DB, Loeser JD. Gram-negative cerebrospinal fluid shunt-associated infections. Pediatrics 1977; 59:614-8.
25. Fan-Havard P, Nahata MC. Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 1987; 6:866-80.
26. Nelson JD. Cerebrospinal fluid shunt infections. Pediatr Infect Dis 1984; 3(3 Suppl):S30-2.
27. Younger JJ, Christensen GD, Bartley DL, et al. Coagulasenegative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome. J Infect Dis 1987; 156:548-54.
28. Kanev PM, Sheehan JM. Reflections on shunt infection. Pediatr Neurosurg 2003; 39:285-90.
29. Gardner P, Leipzig T, Phillips P. Infections of central nervous system shunts. Med Clin North Am 1985; 69:297-314.
30. Gardner P, Leipzig TJ, Sadigh M. Infections of mechanical cerebrospinal fluid shunts. Curr Clin Top Infect Dis 1988; 9:185-214.
31. Morissette I, Gourdeau M, Francoeur J. CSF shunt infections: a fifteen-year experience with emphasis on management and outcome. Can J Neurol Sci 1993; 20:118-22.
32. Venes JL. Infections of CSF shunt and intracranial pressure monitoring devices. Infect Dis Clin North Am 1989; 3:289-99.